wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28073723-D7368CB6-B61C-4F9D-BA10-9D96A7C3536F
Q28073723-D7368CB6-B61C-4F9D-BA10-9D96A7C3536F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28073723-D7368CB6-B61C-4F9D-BA10-9D96A7C3536F
Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?
P2860
Q28073723-D7368CB6-B61C-4F9D-BA10-9D96A7C3536F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28073723-D7368CB6-B61C-4F9D-BA10-9D96A7C3536F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee4bd3e7c1776d3b455fcd4018f140fb2185f0bf
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.